Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.

Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C.

J Mol Biol. 2008 Dec 31;384(5):1143-56. doi: 10.1016/j.jmb.2008.09.008. Epub 2008 Sep 16.

2.

Advances in NKG2D ligand recognition and responses by NK cells.

Le Bert N, Gasser S.

Immunol Cell Biol. 2014 Mar;92(3):230-6. doi: 10.1038/icb.2013.111. Epub 2014 Jan 21. Review.

PMID:
24445601
3.

NKG2D and Related Immunoreceptors.

Strong RK, McFarland BJ.

Adv Protein Chem. 2004;68:281-312. Review.

PMID:
15500864
4.

NKG2D ligands as therapeutic targets.

Spear P, Wu MR, Sentman ML, Sentman CL.

Cancer Immun. 2013 May 1;13:8. Print 2013. Review.

5.

Engineering the variable region of therapeutic IgG antibodies.

Igawa T, Tsunoda H, Kuramochi T, Sampei Z, Ishii S, Hattori K.

MAbs. 2011 May-Jun;3(3):243-52. Epub 2011 May 1. Review.

6.

Mining human antibody repertoires.

Beerli RR, Rader C.

MAbs. 2010 Jul-Aug;2(4):365-78. Epub 2010 Jul 1. Review.

7.

[Monoclonal antibodies against human T-lymphocytes].

Płuzańska A, Robak T.

Pol Arch Med Wewn. 1983 Feb;69(2):157-62. Review. Polish. No abstract available.

PMID:
6351031
8.

A current perspective on applications of macrocyclic-peptide-based high-affinity ligands.

Leenheer D, Ten Dijke P, Hipolito CJ.

Biopolymers. 2016 Nov;106(6):889-900. doi: 10.1002/bip.22900. Review.

9.

From rabbit antibody repertoires to rabbit monoclonal antibodies.

Weber J, Peng H, Rader C.

Exp Mol Med. 2017 Mar 24;49(3):e305. doi: 10.1038/emm.2017.23. Review.

Supplemental Content

Support Center